The Market's Misfits: Why 9 Overlooked Hong Kong Stocks Tell a Bigger StoryGlobal Report·23 hours ago02883-2.50%01798-1.28%
Market Unbundling: From Narrative Arbitrage to Physical Value ChainsGlobal Report·1 day ago, 04:21 AMHOLO+4.40%03880-3.85%
Real Estate's AI Pivot and Macau's Summer Slump: Moves in HK FringesGlobal Report·Aug 11 at 04:43 AM01592-5.61%06687+5.18%
Hong Kong's Micro-Divergence: From JNBY's Breakout to Traditional Consumption PainsGlobal Report·Aug 6 at 04:15 AM02605-2.95%03306-0.05%
Medtide unit Chinese Peptide completes US FDA pre-license inspection for Hepcludex API facilityPUBT·Jul 31 at 03:35 AM03880-3.85%
Medtide expects H1 profit to fall 44%-52% to RMB 49.4 million-RMB 57.1 millionPUBT·Jul 31 at 03:33 AM03880-3.85%
Niche Hong Kong Equities See Independent Catalysts From On-Device AI to Aviation Fleet ExpansionGlobal Report·Jul 30 at 04:14 AM03268+3.54%02665+2.39%
HK Niche Leaders Push Forward With Key Expansions and IPOsGlobal Report·Jul 22 at 04:17 AM01318+3.24%01180+1.08%
Medtide amends articles of association, scraps supervisory committeePUBT·Jun 18 at 06:29 AM03880-3.85%
Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality ConcernsSimplywall·Mar 31 at 08:46 AM520500+2.71%513120+1.43%
"Performance" Medtide Inc. achieved a net profit of RMB 217 million for the year, an increase of 267.3%AASTOCKS·Mar 30 at 09:03 PM520500+2.71%300347-2.72%
Medtide Sets Board Meeting to Approve 2025 Annual Results and Consider Final DividendTip Ranks·Mar 16 at 10:10 AM03880-3.85%
Medtide Inc. is expected to see its profit increase by more than 2.3 times to 2.8 times year-on-year last yearAASTOCKS·Feb 25 at 07:10 PM516500+0.15%03880-3.85%
